tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

INZY Stock Latest News

Inozyme initiated with an Outperform at Raymond James
The FlyInozyme initiated with an Outperform at Raymond James
10d ago
INZY
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
PremiumCompany Announcements
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
2M ago
INZY
Inozyme reports Q3 EPS (39c), consensus (44c)
PremiumThe Fly
Inozyme reports Q3 EPS (39c), consensus (44c)
2M ago
INZY
Is INZY a Buy, Before Earnings?
PremiumPre-Earnings
Is INZY a Buy, Before Earnings?
2M ago
INZY
Inozyme Pharma Reports Promising Results in SEAPORT 1 Trial
PremiumCompany Announcements
Inozyme Pharma Reports Promising Results in SEAPORT 1 Trial
2M ago
8K
INZY
Inozyme announces ‘positive’ interim data from ongoing Phase 1 SEAPORT 1 trial
PremiumThe FlyInozyme announces ‘positive’ interim data from ongoing Phase 1 SEAPORT 1 trial
2M ago
INZY
Inozyme Pharma Welcomes New Director Erik Harris
Premium
Company Announcements
Inozyme Pharma Welcomes New Director Erik Harris
3M ago
8K
INZY
Inozyme appoints Erik Harris to board of directors
Premium
The Fly
Inozyme appoints Erik Harris to board of directors
3M ago
INZY
RARE
Inozyme presents new data at ASBMR 2024 annual meeting
PremiumThe Fly
Inozyme presents new data at ASBMR 2024 annual meeting
3M ago
INZY
Inozyme initiated with a Buy at Stifel
PremiumThe Fly
Inozyme initiated with a Buy at Stifel
3M ago
INZY
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
4M ago
INZY
TNGX
3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts 
4M ago
INZY
SKWD
Inozyme assumed with a Buy at Jefferies
PremiumThe FlyInozyme assumed with a Buy at Jefferies
4M ago
INZY
Inozyme reports Q2 EPS (44c), consensus (39c)
Premium
The Fly
Inozyme reports Q2 EPS (44c), consensus (39c)
5M ago
INZY
Inozyme announces publication of preclinical data on INZ-701
Premium
The Fly
Inozyme announces publication of preclinical data on INZ-701
5M ago
INZY
Inozyme’s INZ-701 awarded Fast Track designation by FDA
PremiumThe Fly
Inozyme’s INZ-701 awarded Fast Track designation by FDA
6M ago
INZY
Inozyme initiated with an Overweight at Wells Fargo
PremiumThe Fly
Inozyme initiated with an Overweight at Wells Fargo
7M ago
INZY
Inozyme expects cash to fund operations into Q4 of 2025
PremiumThe Fly
Inozyme expects cash to fund operations into Q4 of 2025
8M ago
INZY
Inozyme reports Q1 EPS (38c), consensus (36c)
PremiumThe Fly
Inozyme reports Q1 EPS (38c), consensus (36c)
8M ago
INZY
Inozyme reports inducement grants under Nasdaq listing rule
PremiumThe FlyInozyme reports inducement grants under Nasdaq listing rule
8M ago
INZY
Inozyme management to meet with Piper Sandler
Premium
The Fly
Inozyme management to meet with Piper Sandler
8M ago
INZY
Inozyme management to meet with Piper Sandler
Premium
The Fly
Inozyme management to meet with Piper Sandler
8M ago
INZY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >